Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Analgesics, Opioid | 13 | 2018 | 219 | 3.180 |
Why?
|
| Rats | 41 | 2020 | 1699 | 2.220 |
Why?
|
| Conditioning, Operant | 7 | 2014 | 96 | 1.920 |
Why?
|
| Rats, Inbred F344 | 23 | 2018 | 126 | 1.870 |
Why?
|
| Heroin | 8 | 2011 | 14 | 1.870 |
Why?
|
| Cocaine | 11 | 2020 | 259 | 1.640 |
Why?
|
| Spinal Nerves | 8 | 2020 | 66 | 1.610 |
Why?
|
| Reaction Time | 4 | 2018 | 120 | 1.520 |
Why?
|
| Hyperalgesia | 10 | 2020 | 85 | 1.500 |
Why?
|
| Receptors, Opioid, mu | 5 | 2015 | 50 | 1.490 |
Why?
|
| Animals | 47 | 2020 | 7456 | 1.460 |
Why?
|
| Choice Behavior | 3 | 2020 | 80 | 1.400 |
Why?
|
| Attention | 3 | 2018 | 81 | 1.370 |
Why?
|
| Pain Measurement | 9 | 2018 | 365 | 1.360 |
Why?
|
| Self Administration | 17 | 2020 | 296 | 1.350 |
Why?
|
| Pain, Postoperative | 7 | 2018 | 177 | 1.350 |
Why?
|
| Brain | 7 | 2020 | 955 | 1.270 |
Why?
|
| Behavior, Animal | 10 | 2017 | 264 | 1.270 |
Why?
|
| Photic Stimulation | 2 | 2017 | 154 | 1.160 |
Why?
|
| Nucleus Accumbens | 8 | 2018 | 92 | 1.130 |
Why?
|
| Neuralgia | 5 | 2019 | 48 | 1.080 |
Why?
|
| Morphine | 5 | 2012 | 55 | 0.960 |
Why?
|
| Electric Stimulation | 3 | 2012 | 102 | 0.950 |
Why?
|
| Self Stimulation | 4 | 2014 | 4 | 0.890 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 5 | 2015 | 24 | 0.870 |
Why?
|
| Injections, Spinal | 8 | 2013 | 114 | 0.870 |
Why?
|
| Male | 42 | 2020 | 17995 | 0.850 |
Why?
|
| Reward | 2 | 2011 | 61 | 0.830 |
Why?
|
| Neurons | 3 | 2018 | 397 | 0.810 |
Why?
|
| Pain | 5 | 2016 | 262 | 0.800 |
Why?
|
| Pain Threshold | 7 | 2020 | 94 | 0.800 |
Why?
|
| Naltrexone | 5 | 2011 | 38 | 0.780 |
Why?
|
| Laparotomy | 5 | 2011 | 32 | 0.780 |
Why?
|
| Dose-Response Relationship, Drug | 15 | 2018 | 656 | 0.780 |
Why?
|
| Analgesics | 4 | 2017 | 126 | 0.780 |
Why?
|
| Ventral Tegmental Area | 5 | 2018 | 31 | 0.740 |
Why?
|
| Receptors, Opioid, kappa | 2 | 2016 | 40 | 0.730 |
Why?
|
| Cues | 2 | 2017 | 63 | 0.700 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 70 | 0.690 |
Why?
|
| Abdominal Pain | 1 | 2017 | 46 | 0.650 |
Why?
|
| Spinal Cord | 6 | 2018 | 127 | 0.640 |
Why?
|
| Heroin Dependence | 2 | 2007 | 4 | 0.630 |
Why?
|
| Rats, Sprague-Dawley | 14 | 2020 | 801 | 0.600 |
Why?
|
| Arvicolinae | 1 | 2015 | 2 | 0.600 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2006 | 39 | 0.580 |
Why?
|
| Disease Models, Animal | 9 | 2019 | 1021 | 0.570 |
Why?
|
| Narcotics | 4 | 2007 | 19 | 0.560 |
Why?
|
| Motor Activity | 4 | 2014 | 322 | 0.560 |
Why?
|
| Ligation | 4 | 2019 | 60 | 0.540 |
Why?
|
| Sex Characteristics | 1 | 2015 | 172 | 0.540 |
Why?
|
| Foot Injuries | 1 | 2014 | 9 | 0.530 |
Why?
|
| Inflammation | 2 | 2017 | 497 | 0.530 |
Why?
|
| Narcotic Antagonists | 4 | 2011 | 48 | 0.530 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 97 | 0.530 |
Why?
|
| Methadone | 3 | 2011 | 12 | 0.520 |
Why?
|
| Nasal Decongestants | 1 | 2013 | 2 | 0.490 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 2020 | 120 | 0.490 |
Why?
|
| Tachycardia, Ventricular | 1 | 2013 | 13 | 0.490 |
Why?
|
| Methamphetamine | 1 | 2013 | 16 | 0.490 |
Why?
|
| Clonidine | 3 | 2011 | 53 | 0.480 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2012 | 8 | 0.460 |
Why?
|
| Anesthetics, Local | 1 | 2012 | 94 | 0.430 |
Why?
|
| Amygdala | 1 | 2011 | 58 | 0.410 |
Why?
|
| Dopamine | 3 | 2015 | 223 | 0.410 |
Why?
|
| Isothiocyanates | 2 | 2008 | 6 | 0.410 |
Why?
|
| Globus Pallidus | 2 | 2007 | 7 | 0.400 |
Why?
|
| Food | 3 | 2019 | 45 | 0.390 |
Why?
|
| Cyclooxygenase 2 | 2 | 2006 | 53 | 0.380 |
Why?
|
| Electrodes, Implanted | 3 | 2014 | 39 | 0.350 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 4 | 2015 | 18 | 0.350 |
Why?
|
| Cannabinoids | 2 | 2020 | 36 | 0.350 |
Why?
|
| Opioid-Related Disorders | 1 | 2008 | 39 | 0.340 |
Why?
|
| Ketorolac | 2 | 2005 | 24 | 0.340 |
Why?
|
| Exploratory Behavior | 2 | 2005 | 30 | 0.340 |
Why?
|
| Mechanoreceptors | 3 | 2020 | 38 | 0.330 |
Why?
|
| Infusions, Intravenous | 4 | 2011 | 88 | 0.320 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2018 | 79 | 0.320 |
Why?
|
| Drug Tolerance | 1 | 2007 | 37 | 0.320 |
Why?
|
| Spinal Cord Diseases | 1 | 2006 | 7 | 0.320 |
Why?
|
| Transferases | 1 | 2006 | 1 | 0.320 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2006 | 6 | 0.320 |
Why?
|
| Receptors, Opioid, delta | 1 | 2006 | 17 | 0.310 |
Why?
|
| Cyclooxygenase 1 | 1 | 2006 | 22 | 0.310 |
Why?
|
| Spinal Cord Injuries | 1 | 2006 | 27 | 0.300 |
Why?
|
| Cocaine-Related Disorders | 2 | 2015 | 104 | 0.300 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2019 | 73 | 0.290 |
Why?
|
| Hypertension | 1 | 2013 | 948 | 0.290 |
Why?
|
| Abdomen | 1 | 2005 | 44 | 0.280 |
Why?
|
| Neural Conduction | 2 | 2016 | 77 | 0.280 |
Why?
|
| Adenosine | 3 | 2011 | 40 | 0.270 |
Why?
|
| Acetylcholine | 1 | 2004 | 40 | 0.260 |
Why?
|
| Time Factors | 8 | 2017 | 2000 | 0.260 |
Why?
|
| Autoradiography | 3 | 2015 | 48 | 0.240 |
Why?
|
| Nociceptors | 2 | 2020 | 40 | 0.240 |
Why?
|
| Cyclohexanols | 2 | 2020 | 20 | 0.240 |
Why?
|
| Data Interpretation, Statistical | 2 | 2014 | 106 | 0.240 |
Why?
|
| Ganglia, Spinal | 2 | 2020 | 63 | 0.220 |
Why?
|
| Carbon Radioisotopes | 1 | 2020 | 21 | 0.200 |
Why?
|
| Microtubules | 1 | 2020 | 18 | 0.200 |
Why?
|
| Quinazolines | 1 | 2020 | 37 | 0.200 |
Why?
|
| Hydromorphone | 2 | 2011 | 4 | 0.200 |
Why?
|
| Food Preferences | 1 | 2020 | 38 | 0.190 |
Why?
|
| Radiopharmaceuticals | 1 | 2020 | 86 | 0.190 |
Why?
|
| Fentanyl | 2 | 2011 | 32 | 0.190 |
Why?
|
| Drug Synergism | 3 | 2011 | 66 | 0.180 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 170 | 0.180 |
Why?
|
| Eating | 3 | 2015 | 71 | 0.170 |
Why?
|
| Analysis of Variance | 3 | 2014 | 472 | 0.170 |
Why?
|
| Action Potentials | 1 | 2018 | 168 | 0.170 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2017 | 33 | 0.170 |
Why?
|
| Alkylation | 2 | 2007 | 5 | 0.160 |
Why?
|
| Binding, Competitive | 2 | 2007 | 37 | 0.160 |
Why?
|
| Radioligand Assay | 2 | 2007 | 23 | 0.160 |
Why?
|
| Triazoles | 1 | 2016 | 14 | 0.160 |
Why?
|
| Drug Interactions | 2 | 2006 | 84 | 0.150 |
Why?
|
| Pruritus | 1 | 2016 | 60 | 0.150 |
Why?
|
| Macaca mulatta | 4 | 2020 | 322 | 0.150 |
Why?
|
| Stress, Psychological | 1 | 2018 | 213 | 0.150 |
Why?
|
| Sulfur Radioisotopes | 1 | 2015 | 9 | 0.150 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2015 | 13 | 0.150 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2015 | 4 | 0.150 |
Why?
|
| Neuroglia | 1 | 2015 | 33 | 0.150 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2015 | 29 | 0.150 |
Why?
|
| Circadian Rhythm | 2 | 2006 | 46 | 0.140 |
Why?
|
| Heart Arrest | 1 | 2015 | 37 | 0.140 |
Why?
|
| Phenmetrazine | 1 | 2015 | 4 | 0.140 |
Why?
|
| Analgesia | 1 | 2015 | 32 | 0.140 |
Why?
|
| Microdialysis | 2 | 2006 | 32 | 0.140 |
Why?
|
| Stereotyped Behavior | 2 | 2005 | 13 | 0.140 |
Why?
|
| Echocardiography | 1 | 2015 | 146 | 0.140 |
Why?
|
| Norepinephrine | 1 | 2015 | 69 | 0.140 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2014 | 32 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2015 | 213 | 0.130 |
Why?
|
| Cognition | 1 | 2017 | 529 | 0.120 |
Why?
|
| Breast Cyst | 1 | 2013 | 2 | 0.120 |
Why?
|
| Administration, Inhalation | 1 | 2013 | 91 | 0.120 |
Why?
|
| Physical Stimulation | 2 | 2016 | 84 | 0.120 |
Why?
|
| Oxycodone | 1 | 2011 | 6 | 0.110 |
Why?
|
| Corticosterone | 1 | 2011 | 10 | 0.110 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2011 | 20 | 0.110 |
Why?
|
| Amines | 1 | 2011 | 22 | 0.110 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2011 | 13 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2015 | 275 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2015 | 717 | 0.110 |
Why?
|
| Fever | 1 | 2011 | 55 | 0.110 |
Why?
|
| Lipopolysaccharides | 1 | 2011 | 106 | 0.110 |
Why?
|
| Pressure | 1 | 2011 | 54 | 0.110 |
Why?
|
| Microglia | 1 | 2010 | 47 | 0.100 |
Why?
|
| Protein Binding | 2 | 2008 | 192 | 0.100 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2008 | 19 | 0.090 |
Why?
|
| Nortropanes | 1 | 2008 | 2 | 0.090 |
Why?
|
| Tropanes | 1 | 2008 | 9 | 0.090 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2008 | 16 | 0.090 |
Why?
|
| Humans | 5 | 2015 | 28452 | 0.090 |
Why?
|
| Corpus Striatum | 1 | 2008 | 59 | 0.080 |
Why?
|
| Alkylating Agents | 1 | 2007 | 4 | 0.080 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2008 | 96 | 0.080 |
Why?
|
| Female | 3 | 2015 | 18228 | 0.080 |
Why?
|
| Microinjections | 2 | 2004 | 34 | 0.080 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 70 | 0.080 |
Why?
|
| Macaca fascicularis | 2 | 2020 | 390 | 0.080 |
Why?
|
| Sulfur Isotopes | 1 | 2006 | 2 | 0.080 |
Why?
|
| Theophylline | 1 | 2006 | 4 | 0.080 |
Why?
|
| Phosphatidylethanolamines | 1 | 2006 | 2 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2008 | 372 | 0.080 |
Why?
|
| Nitrobenzenes | 1 | 2006 | 10 | 0.080 |
Why?
|
| Sensory Thresholds | 1 | 2006 | 27 | 0.080 |
Why?
|
| Functional Laterality | 1 | 2006 | 60 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2006 | 55 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2006 | 63 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2007 | 109 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2006 | 69 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 259 | 0.070 |
Why?
|
| Ileus | 1 | 2005 | 6 | 0.070 |
Why?
|
| Abdominal Muscles | 1 | 2005 | 8 | 0.070 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 32 | 0.070 |
Why?
|
| Brain Chemistry | 1 | 2005 | 32 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2005 | 25 | 0.070 |
Why?
|
| Bupivacaine | 1 | 2005 | 56 | 0.070 |
Why?
|
| Osteoclasts | 1 | 2005 | 22 | 0.070 |
Why?
|
| Drug Combinations | 1 | 2005 | 84 | 0.070 |
Why?
|
| Sucrose | 1 | 2004 | 17 | 0.070 |
Why?
|
| Feeding Behavior | 1 | 2006 | 164 | 0.070 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 1 | 2004 | 6 | 0.070 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2004 | 5 | 0.070 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2004 | 10 | 0.070 |
Why?
|
| Cholinergic Agents | 1 | 2004 | 6 | 0.070 |
Why?
|
| Immunotoxins | 1 | 2004 | 15 | 0.070 |
Why?
|
| Oxidopamine | 1 | 2003 | 6 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 68 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2014 | 38 | 0.060 |
Why?
|
| Injections, Intraventricular | 1 | 2002 | 16 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 192 | 0.060 |
Why?
|
| Middle Aged | 2 | 2013 | 11102 | 0.050 |
Why?
|
| Touch | 1 | 2020 | 35 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2006 | 3025 | 0.040 |
Why?
|
| Psychology | 1 | 2018 | 21 | 0.040 |
Why?
|
| Cercopithecidae | 1 | 2017 | 10 | 0.040 |
Why?
|
| Receptors, Cannabinoid | 1 | 2017 | 27 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2011 | 790 | 0.040 |
Why?
|
| Pyramidal Tracts | 1 | 2015 | 3 | 0.040 |
Why?
|
| Imidazoles | 1 | 2015 | 118 | 0.030 |
Why?
|
| Proton Pumps | 1 | 2014 | 7 | 0.030 |
Why?
|
| Neurofilament Proteins | 1 | 2014 | 11 | 0.030 |
Why?
|
| Dependovirus | 1 | 2014 | 21 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2014 | 71 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2014 | 76 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 67 | 0.030 |
Why?
|
| Cardiology | 1 | 2015 | 74 | 0.030 |
Why?
|
| Emergency Medicine | 1 | 2015 | 133 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 462 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 778 | 0.030 |
Why?
|
| Macrophages, Peritoneal | 1 | 2011 | 19 | 0.030 |
Why?
|
| Immunization | 1 | 2011 | 27 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2011 | 30 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2010 | 4 | 0.030 |
Why?
|
| Mice | 1 | 2016 | 2372 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 202 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2008 | 50 | 0.020 |
Why?
|
| Morphine Derivatives | 1 | 2005 | 3 | 0.020 |
Why?
|
| Prosencephalon | 1 | 2005 | 6 | 0.020 |
Why?
|
| Membranes | 1 | 2005 | 12 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2005 | 1 | 0.020 |
Why?
|
| Osteopetrosis | 1 | 2005 | 2 | 0.020 |
Why?
|
| Oxazines | 1 | 2005 | 2 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2005 | 3 | 0.020 |
Why?
|
| Cathepsins | 1 | 2005 | 2 | 0.020 |
Why?
|
| Xanthenes | 1 | 2005 | 4 | 0.020 |
Why?
|
| Chloride Channels | 1 | 2005 | 7 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2005 | 6 | 0.020 |
Why?
|
| Macrolides | 1 | 2005 | 8 | 0.020 |
Why?
|
| Bone Resorption | 1 | 2005 | 14 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2005 | 14 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2005 | 15 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2005 | 64 | 0.020 |
Why?
|
| Ovary | 1 | 2005 | 53 | 0.020 |
Why?
|
| Family Health | 1 | 2005 | 90 | 0.020 |
Why?
|
| Tetrazoles | 1 | 2005 | 99 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2005 | 80 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 489 | 0.020 |
Why?
|
| Neostriatum | 1 | 2003 | 21 | 0.020 |
Why?
|
| Bone Density | 1 | 2005 | 198 | 0.020 |
Why?
|
| Macrophages | 1 | 2005 | 191 | 0.020 |
Why?
|
| Reinforcement Schedule | 1 | 2003 | 60 | 0.020 |
Why?
|
| Phenotype | 1 | 2005 | 662 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 369 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 454 | 0.010 |
Why?
|
| Adult | 1 | 2005 | 8519 | 0.010 |
Why?
|